Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Lexeo Therapeutics, Inc. (LXEO) had Debt to Capital Ratio of 0.01 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-32.66M |
|
-- |
|
-- |
|
$33.80M |
|
$-33.80M |
|
$1.15M |
|
$-32.66M |
|
$-32.66M |
|
$-32.66M |
|
$-32.66M |
|
$-32.66M |
|
$-32.66M |
|
$-33.80M |
|
$-33.74M |
|
33.11M |
|
33.11M |
|
$-0.99 |
|
$-0.99 |
|
| Balance Sheet Financials | |
$105.27M |
|
$1.04M |
|
$20.42M |
|
$125.69M |
|
$30.82M |
|
$0.70M |
|
$6.75M |
|
$37.58M |
|
$88.11M |
|
$88.11M |
|
$88.11M |
|
33.19M |
|
| Cash Flow Statement Financials | |
$-21.72M |
|
$15.60M |
|
$0.01M |
|
$38.27M |
|
$32.16M |
|
$-6.11M |
|
$3.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.42 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.01 |
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.72M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-37.06% |
|
-37.06% |
|
-25.98% |
|
-36.77% |
|
$2.65 |
|
$-0.66 |
|
$-0.66 |
|